3.16
price down icon0.32%   -0.010
after-market Handel nachbörslich: 3.22 0.06 +1.90%
loading
Schlusskurs vom Vortag:
$3.17
Offen:
$3.17
24-Stunden-Volumen:
320.13K
Relative Volume:
0.55
Marktkapitalisierung:
$174.86M
Einnahmen:
$163.78M
Nettoeinkommen (Verlust:
$25.88M
KGV:
4.8615
EPS:
0.65
Netto-Cashflow:
$-28.66M
1W Leistung:
+2.76%
1M Leistung:
+6.40%
6M Leistung:
-41.80%
1J Leistung:
-63.97%
1-Tages-Spanne:
Value
$3.16
$3.25
1-Wochen-Bereich:
Value
$3.15
$3.36
52-Wochen-Spanne:
Value
$2.645
$9.55

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Name
Firmenname
Voyager Therapeutics Inc
Name
Telefon
857-259-5340
Name
Adresse
75 HAYDEN AVENUE, LEXINGTON, MA
Name
Mitarbeiter
172
Name
Twitter
@VoyagerTx
Name
Nächster Verdiensttermin
2025-03-11
Name
Neueste SEC-Einreichungen
Name
VYGR's Discussions on Twitter

Vergleichen Sie VYGR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VYGR
Voyager Therapeutics Inc
3.16 170.16M 163.78M 25.88M -28.66M 0.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-10 Eingeleitet Cantor Fitzgerald Overweight
2024-12-02 Eingeleitet Citigroup Buy
2024-11-29 Fortgesetzt Wedbush Outperform
2024-10-16 Eingeleitet Leerink Partners Outperform
2024-03-26 Eingeleitet Guggenheim Buy
2024-03-19 Eingeleitet H.C. Wainwright Buy
2024-03-07 Eingeleitet Citigroup Buy
2024-01-02 Hochstufung Wells Fargo Equal Weight → Overweight
2023-05-10 Eingeleitet Truist Buy
2023-03-10 Eingeleitet Oppenheimer Outperform
2021-10-07 Hochstufung Robert W. Baird Neutral → Outperform
2021-02-26 Herabstufung Robert W. Baird Outperform → Neutral
2021-02-03 Herabstufung BTIG Research Buy → Neutral
2021-02-03 Herabstufung Wedbush Outperform → Neutral
2020-12-24 Herabstufung Cantor Fitzgerald Overweight → Neutral
2020-12-23 Herabstufung Raymond James Outperform → Mkt Perform
2020-11-11 Herabstufung Oppenheimer Outperform → Perform
2020-11-10 Herabstufung Raymond James Strong Buy → Outperform
2020-11-10 Herabstufung Wells Fargo Overweight → Equal Weight
2020-03-19 Eingeleitet The Benchmark Company Buy
2020-02-06 Eingeleitet Oppenheimer Outperform
2018-11-15 Hochstufung Raymond James Outperform → Strong Buy
2018-09-10 Fortgesetzt BTIG Research Buy
2018-09-10 Herabstufung Morgan Stanley Overweight → Equal-Weight
2018-06-04 Eingeleitet H.C. Wainwright Buy
2018-03-12 Herabstufung Evercore ISI Outperform → In-line
2018-03-12 Herabstufung Wedbush Outperform → Neutral
2018-02-02 Eingeleitet Morgan Stanley Overweight
2017-11-28 Fortgesetzt Piper Jaffray Overweight
2017-10-31 Eingeleitet Robert W. Baird Outperform
2017-10-27 Eingeleitet Canaccord Genuity Buy
2017-10-23 Bestätigt Stifel Buy
2017-10-12 Eingeleitet Raymond James Outperform
2017-08-17 Eingeleitet Evercore ISI Outperform
2017-07-28 Fortgesetzt Stifel Buy
Alle ansehen

Voyager Therapeutics Inc Aktie (VYGR) Neueste Nachrichten

pulisher
Jul 22, 2025

What drives Voyager Therapeutics Inc. stock priceTriple-digit returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Voyager Therapeutics Inc. a good long term investmentGame-changing returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Voyager Therapeutics Inc. Stock Analysis and ForecastUnmatched market gains - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Why Voyager Therapeutics Inc. stock attracts strong analyst attentionFree Smart Money Stock Analysis - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Voyager Therapeutics’ Promising Alzheimer’s Study: A Potential Game-Changer? - MSN

Jul 22, 2025
pulisher
Jul 20, 2025

Why did Voyager's net profit surge in Q4 2024 despite high operating expenses? - AInvest

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Voyager Therapeutics Inc. stockMarket-crushing stock picks - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Does Voyager Therapeutics Inc. stock pay reliable dividendsTrend Based Entry Alerts - beatles.ru

Jul 19, 2025
pulisher
Jul 17, 2025

Voyager Therapeutics adds new gene therapy to Alzheimer’s program - BioWorld MedTech

Jul 17, 2025
pulisher
Jul 17, 2025

Baird reiterates Outperform rating on Voyager Therapeutics stock with $18 price target - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease - GlobeNewswire

Jul 17, 2025
pulisher
Jul 16, 2025

How Voyager Therapeutics Inc. stock performs during market volatilityDaily Top Gainers - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Voyager Therapeutics Introduces New Program Targeting Genetic Risk Factor of Alzheimer's Disease - 富途牛牛

Jul 16, 2025
pulisher
Jul 16, 2025

Voyager Therapeutics Launches New Gene Therapy Program Targeting APOE for Alzheimer's Disease Treatment - Quiver Quantitative

Jul 16, 2025
pulisher
Jul 16, 2025

Voyager Therapeutics unveils APOE-targeting Alzheimer’s therapy program By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 16, 2025

Voyager Therapeutics unveils APOE-targeting Alzheimer’s therapy program - Investing.com

Jul 16, 2025
pulisher
Jul 16, 2025

Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach - GlobeNewswire Inc.

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Voyager Therapeutics Inc. stock price move sharplyBreakout Setup Scanner - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Allspring Global Investments Holdings LLC Buys 21,149 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jul 12, 2025
pulisher
Jul 05, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Brokerages - Defense World

Jul 05, 2025
pulisher
Jun 25, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Rhumbline Advisers - Defense World

Jun 25, 2025
pulisher
Jun 18, 2025

Financial Comparison: Prime Medicine (NYSE:PRME) & Voyager Therapeutics (NASDAQ:VYGR) - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Voyager Therapeutics at H.C. Wainwright: Genetic Innovation in Focus By Investing.com - Investing.com Canada

Jun 17, 2025
pulisher
Jun 11, 2025

Equities Analysts Offer Predictions for VYGR FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspecti - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference | VYGR Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewswire

Jun 10, 2025
pulisher
Jun 09, 2025

Millennium Management LLC Sells 60,935 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Decreases Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Voyager Therapeutics: Navigating AAV Headwinds And A Long Road For VY7523 (Downgrade) - Seeking Alpha

Jun 06, 2025
pulisher
Jun 05, 2025

Voyager Therapeutics Approves Stock Plans at Annual Meeting - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Sells 43,210 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Holdings Lowered by ProShare Advisors LLC - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Cuts Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews

Jun 02, 2025
pulisher
Jun 01, 2025

Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Jun 01, 2025
pulisher
May 31, 2025

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Jane Street Group LLC - Defense World

May 31, 2025
pulisher
May 31, 2025

Voyager Therapeutics stock plunges to 52-week low of $2.71 By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 31, 2025

Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 31, 2025

Finanzdaten der Voyager Therapeutics Inc-Aktie (VYGR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):